$APRE

$0.80▲ +8.1% YTD

4 SEC 13D/G filings tracked · Last updated Sep 22, 2026

Filing History

CP $0.80▲ +8.1%Sep 22, 2026 · ThinkSabio Blog

$APRE - Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium…

News

APRE ▲ +2.5% - Aprea Therapeutics, Inc.

CP $0.81▲ +2.5%Sep 10, 2026 · ThinkSabio Blog

$APRE - Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference…

News

APRE ▲ +4.7% - Aprea Therapeutics, Inc.

CP $0.90▲ +4.7%Aug 28, 2026 · ThinkSabio Blog

$APRE - Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs…

SEC 13D/G

APRE - Aprea Therapeutics, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$0.66▼ -22.35%Aug 13, 2026 · ThinkSabio Blog

$APRE SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #APRE Aprea Therapeutics, Inc. : $0.66 Sector: Healthcare | YTD:…